Expert consensus for diagnosis and treatment of refractory generalized myasthenia gravis in China(2024)
Refractory generalized myasthenia gravis(gMG)is a subtype of myasthenia gravis that exhibits limited response to conventional immunosuppressive drugs or has a tendency for recurrence,thereby posing challenges in achieving treatment goals.To establish the consensus on diagnostic criteria and treatment protocols of refractory gMG,experts from the Neurology Society of China Alliance for Rare Diseases,Chinese Myasthenia Gravis Collaboration Group and Chinese Society of Neuromuscular Disease have developed this consensus.The consensus consists of diagnostic criteria,risk factors,antibody revalidation,identification of comorbidities,and treatment approaches for refractory gMG.
NETL
NSTL
万方数据
